caffeic acid phenethyl ester has been researched along with cyqualon in 1 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (cyqualon) | Trials (cyqualon) | Recent Studies (post-2010) (cyqualon) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 24 | 0 | 5 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | cyqualon (IC50) |
|---|---|---|---|
| nonstructural protein 1 | Influenza A virus (A/California/07/2009(H1N1)) | 100 | |
| tumor necrosis factor | Homo sapiens (human) | 3.5965 | |
| nucleotide-binding oligomerization domain-containing protein 2 isoform 1 | Homo sapiens (human) | 3.749 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assefa, H; Buolamwini, JK | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and cyqualon
| Article | Year |
|---|---|
CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
Topics: Binding Sites; Cinnamates; HIV Integrase Inhibitors; HIV-1; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship | 2002 |